Matthias Baier

2024: Coming to end. When I reflect back, I could see that its been a great year for me , in every possible way. Develop M3: Each one of them have their unique role to play and add their own strength to your goal and strategizing them. Let me explain first their components: 1)  Mind : Includes knowledge, Information, strategy 2)  Muscle: Physical, Emotional, Mental , Allies, Social , Political 3)  Money: Visible, Invisible, Tangible, Non tangible Stay away from "I" Quattro people : Never wrestle with a pig. You'll both get dirty but only the pig will enjoy it 1) Irresponsible 2) Illogical 3) Irrational and 4) Most importantly IDIOTS Focus on T3 1) Time: Its finite and slipping away. You cannot save it, multiple it, store it , buy it. You just use it every second. Its the most precious commodity in life so use it wisely 2) Task: Prioritize the tasks. What needs to be done has to be done. What is not important can wait 3) Threats: Life is a threat at each moment. Life is like crossing the road blindfolded, you don't know what will hit you when. So be prepared for worst all the time: Emotionally, Mentally, Physically, Psychosocially, intellectually and Family wise.

28

2 Kommentare

🎯 The GenAI effect: Redefining the pharma landscape 🎯   Thank you Basel Area Business & Innovation for enabling another phantastic DayOne - Healthcare Innovation / Open Mic event today (September 30) followed by a networking opportunity!   Thank you Dr. Petra Jantzer for the insighful Keynote Lecture, and thank you Davidek Herron, MBA, Tomislav Ilicic and Nikita Popov for sharing your thoughts and visions!   Some key takeaways: 🚀 Generative AI (GenAI) and other Intelligent Technologies have the potential to disrupt the pharma industry and to re-invent the entire value chain. 🚀 Data is Gold, but Data need to be cleaned up, structured and reliable to be applicable to GenAI. 🚀 The work force will be more productive and drug R&D will gain 25-30% efficiency and be less costly. Sample uses cases with high impact are automated document generation, rapid data finding, hyper-personalization of HCP interactions, efficient supply chain management, and competitive differentiation. 🚀 Change management will be at the forefront as required skills will change, roles will change, and companies will face new ways of working.   Rahel Schneider Ursula Costa #BaselAreaBusinessInnovation #LifeSciences #AI #HealthcareInnovation #GenerativeAI

29

3 Kommentare

Great speaking with Florence Vuichard and Pascal Michel for a story in today's "Schweiz am Wochenende". We talked about medicines people urgently need and sometimes cannot get, because current supplies are in different pack sizes than prescribed or because they are warehoused in different countries from which they cannot be imported due to regulatory hurdles. In my view there would be an easy solution: liberalilze the pharmaceutical supply chain accross borders and agree on prices that reflect the true value of essential generic medicines. We also spoke about the medicines everybody wants but nobody can produce enough of: weight-loss drugs. While this is a unique market situation like I have never seen before, we also need address rising environmental concerns with a dramatically growing number of one-time application devices.

254

10 Kommentare

You're wondering how the pharmaceutical and healthcare sectors will evolve in the coming years? So do we! So much in fact that we decided to ask Peter Guenter, CEO Healthcare at Merck KgaA. Here are some key takeaways from his recent interview: 💡Embracing new technologies like mRNA, cell and gene therapies, along with digitalization can open the way to a revolution in patient care. 💡Tailored healthcare solutions require a patient-centric approach powered by digital tools and data analytics. 💡Challenges such as R&D productivity, regulatory landscapes, and the need for global health equity are at the forefront of the industry's evolution. 💡Driving innovation and value for patients requires 'beyond-the-pill' solutions and bioconvergence. 💡Smarter regulation and an enhanced focus on critical areas like antimicrobial resistance (AMR) and health equity can increase global competitiveness and innovation. 🔍Want to know more? You can read the full interview by following the link below: https://pwc.to/3W1YbWU #HealthcareInnovation #PatientCare #DigitalHealth #PwCBelgium

2

⏳ Not much that I can add to avatar Paloma's opinion as we count down to starting Digital Modelling Core 6.2 on Monday together with the Novartis Finance Academy and Prof. Martin Spindler & team: "If you have followed the news last week, you know that it is a perfect timing to familiarize yourself with machine learning: the Nobel prizes for physics and for chemistry were awarded for work that is rooted in AI and ML. On top, we will also encounter towards the end of the training concepts related to causality, for which a Nobel memorial prize was already awarded in 2021. Models play a critical role for machine learning: they are abstract and simplified representations of a reality in physics, in chemistry, or, as in our case, a business reality. Through the DMC, we hope that you will better translate your business requirements into digital models, leading to better decisions." 👋 Paloma and I see you on Monday! 👋

35

2 Kommentare

A little experiment with ChatGPT. Why? Just because. I asked what he/she thinks that our offices look like, he/she replied "one can envision a modern and professional workspace typical of pharmaceutical companies in Switzerland. Such offices often feature contemporary design elements, open-plan layouts to encourage collaboration, dedicated meeting rooms equipped with the latest technology, and areas designed for both focused work and informal discussions." While ChatGPT was slightly off vs. our real offices, we are working hard towards becoming the best we can be. #modernoffice #workplace #reality

31

3 Kommentare

🌟 Women leading change at Sandoz 🌟 Sandoz is leading the way in female representation among major Swiss companies, with 45% of our executives being women, according to an analysis prepared by news wire service AWP Finanznachrichten AG in May this year. And a story published just this week by Swiss national daily Tages-Anzeiger features five women on our executive team driving meaningful change throughout the company 👇 Our corporate culture supports work-life balance, ensuring career progression isn’t hindered by personal responsibilities. Keren Haruvi Snir, President of North America and member of the Sandoz executive team, notes, “I am one and the same person in my private and professional life, and I can stand by that.” Women at Sandoz lead with collaboration and purpose. Chief Scientific Officer Claire D'Abreu-Hayling emphasizes inclusive decision-making, while incoming Chief Commercial Officer Rebecca Guntern believes in keeping patients at the forefront of our work. Chief Legal Officer Ingrid Sollerer aligns her role with her personal values, advocating for affordable medicines. Last but not least, diversity at Sandoz extends beyond gender, incorporating various backgrounds and experiences to fuel innovation. As Chief People Officer Tripti Jha says, “It’s not just about more women, but about more diversity.” Read the full story in German on: https://lnkd.in/dGrW_xBJ Please note a subscription is required to access the full article. #Sandoz #WomenInLeadership #Diversity

621

14 Kommentare

You're wondering how the pharmaceutical and healthcare sectors will evolve in the coming years? So do we! So much in fact that we decided to ask Peter Guenter, CEO Healthcare at Merck KgaA. Here are some key takeaways from his recent interview: 💡Embracing new technologies like mRNA, cell and gene therapies, along with digitalization can open the way to a revolution in patient care. 💡Tailored healthcare solutions require a patient-centric approach powered by digital tools and data analytics. 💡Challenges such as R&D productivity, regulatory landscapes, and the need for global health equity are at the forefront of the industry's evolution. 💡Driving innovation and value for patients requires 'beyond-the-pill' solutions and bioconvergence. 💡Smarter regulation and an enhanced focus on critical areas like antimicrobial resistance (AMR) and health equity can increase global competitiveness and innovation. 🔍Want to know more? You can read the full interview by following the link below: https://pwc.to/3W1YbWU #HealthcareInnovation #PatientCare #DigitalHealth #PwCBelgium

7

Looking for a Sunday read. Enjoy this: MedTech Quality Costs: Beyond Just a 'License to Operate' In the MedTech industry, quality and regulatory compliance have evolved into key drivers of financial success, influencing both operational performance and research and development (R&D) strategies. Companies facing quality and regulatory issues not only compromise patient safety but also experience long-term impacts on their financial competitiveness. While stock markets historically did not consistently penalize MedTech firms for poor quality and regulatory compliance, this trend has changed significantly in recent years. Deloitte's recent paper highlights a widening gap in stock market performance between companies with strong and weak quality and regulatory practices. The data indicates that consistently meeting these standards without sacrificing R&D innovation, agility, and speed is now a crucial strategic advantage. The paper explores the reasons behind this shift and examines how MedTech companies are investing strategically to enhance both compliance and innovation. For more insights, check out Deloitte's full analysis:

9

1 Kommentar

🧡 Celebrating 5 Incredible Years at CSL Vifor Switzerland 🧡 I am thrilled to celebrate my 5th anniversary as Omnichannel Manager at CSL Vifor. These years have been marked by intense collaboration, innovative initiatives, and exciting projects for our customers and patients. 🤝 Teamwork: Working with such great people as well as with dedicated and talented team is an enriching experience. Together, we overcome numerous challenges and reach new heights. 🚀 Initiatives and Innovation: I'm lucky enough to be able to lead initiatives that not only improve our processes, but also stimulate our creativity and ability to innovate. 💃 Skill Development: These years have been a tremendous opportunity for personal and professional growth as well as for continuously developping new skills and deepening my knowledges. 💥  Exciting Projects: Participating in various and stimulating projects has been a true source of motivation. Each project brought its share of challenges and satisfactions. 🤩  Opportunities and Connections: I have had the chance to meet beautiful people and seize unique opportunities that have enriched my journey. 🙏 Support and Trust: A big thank you to my management for its constant support and trust. Its guidance has been essential to our success. I am excited to see what the future holds and to continue contributing to our collective success. Thank you to everyone who has been part of this journey! #Teamwork #Innovation #Leadership #CareerGrowth #Omnichannel

86

14 Kommentare

Brilliant panel discussion on "Investments in Global Healthcare Systems" moderated by André Guedel at #swissbiotechday2024. It effectively highlighted the pivotal role of the Swiss life sciences industry, in collaboration with Swiss government organizations, academic institutions, and Swiss-based non-profit organizations, in shaping healthcare programs worldwide. Especially in Low-Middle-Income Countries #LMICs, #value-based partnerships have a transformative impact on patient access to healthcare. 💡The discussion covered a range of strategies, from funding financial sector partners to develop and scale health insurance products, enabling patients to afford therapies out-of-pocket #SCBF, to collaborating with local governments and organizations like #WHO AFRO to streamline national treatment guidelines and regulatory systems #swissmedic #novartis. Moreover, the panel stressed the significance of harmonizing standards to drive alignment and reduce complexity. 🚀 Despite the brilliant showcase of examples, it is not possible to extrapolate a one-stop-shop solution (yet 😉). Therefore, identifying key stakeholders to address the right challenges early on remains crucial. 🙏🏿Thank you very much to the panelists for the great session! Lutz Hegemann, Michael Altorfer, Jörg Schläpfer, Sitara Merchant #SwissBiotechDay #biotech #healthcare #innovation

22

2 Kommentare

At Merck KGaA, Darmstadt, Germany, we're pushing the boundaries of what's possible with artificial intelligence, and my colleague Philipp Harbach is giving us a sneak peek into how we're advancing across the entire AI value chain. From revolutionizing semiconductor production to accelerating groundbreaking research, we're not just innovating materials and processes—we're also speeding up the discovery of new drugs. But here's the big question: Where do YOU think AI can make the biggest impact? Let's start a conversation—I'd love to hear your thoughts in the comments! 👇 #AI360View

17

Can Germany improve? Sure, what country couldn't? But as the world's third-largest economy, it is also a formidable global economic player. This position isn't just a statistic but proves Germany's enduring drive for innovation and resilience.   However, some voices paint a different picture: That the country has gone down the drain economically in recent years and that it is basically doomed. I disagree with this assessment. Germany is still in a good position to remain an innovative powerhouse. That's why Merck Gruppe has invested billions here in recent years and continues to do so. The latest example is the Advances Research Center of Merck Life Science in Darmstadt. manager magazin has collected many voices on what's good about the German business location. And there's lot to be positive about. Read Merck CEO Belén Garijo 's view on how and why Germany will continue to be successful. https://lnkd.in/drBcxNBQ

74

3 Kommentare

#Decentralizing the #ESG agenda: what can be more exciting and intriguing than this? PS: If you are not able to make it in person due to the waiting list lengths, keep an eye on Crypto Valley Association posts as the plan is to record the event and publish it later See you soon Aliya Das Gupta, Una Wang, Mario Stephan and Jakob Linus Stammler

17

I received more than 100 CVs in 2 days. and that's the best recognition I've ever gotten ❤️ Since I initiated this amazing entrepreneurial journey with my friend Thomas Mrosk, every day looked like a full-immersion masterclass in the AI for Pharma space. I thought I was ready, I felt like I already knew most of the must-know things. I was proved wrong almost daily. ctcHealth, our beloved company, is growing at a speed that goes beyond our most optimistic expectations. Only my joy for this venture grows faster, and I guess people around me can feel my new enthusiasm. "Feedback comes in many forms" some years ago a very wise man told me. Getting more than 100 resumes in 2 days for an internship position is definitely great feedback saying that people are willing to join this journey. And the profiles we received, guys, I'd be honored to have some of you on board. The decision will be tough! Anyhow, the journey has just begun, and everything is new. There's something that would really help us shape this internship experience, answering the following question: "What are you really looking for in an internship?" - P.S. If you are not looking for an internship, think about what would be important for you. --- Hey, I’m Manuel. I write, speak, train and advise on #AI for Pharma Marketing. Enjoyed reading this? 👉 Connect, follow me Manuel Mitola, MBA. ☕ Let's take a virtual coffee: link up top. ♻️ Save or re-post to share with others.

131

6 Kommentare

Last moments at Basel for the Swiss Biotech Days 2024! The health system is moving forward thanks to innovations in research, data, and AI. Great discussions and connections from different players in the field. Let’s keep in touch and wish the best success to new emerging biotech companies! #SwissBiotech #SwissBiotechDay

136

2 Kommentare

Challenge accepted Peter Hallerbäck 💪❤️! I am excited to be part of Amgen's#CheckLDL Testing Challenge to ensure that I stay healthy for my beloved husband Christoph Rinderknecht 🫶🏻 Why? 👉 High levels of low-density lipoprotein cholesterol (often referred to LDL-C or "bad" cholesterol) are one of the main risk factors for heart attacks and strokes. Often, there are no symptoms, making heart disease a silent threat that can affect any of us. Though in Switzerland, we have the fifth-lowest incidence of cardiovascular diseases within the ESC Atlas of Cardiology, it is the leading cause of death, with around 20,000 people dying from it annually. This highlights the urgent need for preventive action. As we approach #WorldHeartDay on September 29, it is even more important to prioritize our heart health. Schedule an appointment with your doctor to check your low-density lipoprotein cholesterol levels, and encourage your loved ones to do the same. Small preventive steps can make a big difference. *Are you joining me Marco Schütz Fabiano Cusmano and Diana Trentin ?* Let’s raise awareness about heart health and encourage others to join the movement! 📢 #mycompany #CheckLDL #WorldHeartDay

23

#News: Roche (ROG.S),  on Thursday raised its full-year earnings forecast after exceeding expectations for the first half, driven by strong demand for newer drugs such as #eyemedicine #Vabysmo. The Swiss drugmaker said it expects growth in adjusted earnings in the "high single-digit range", excluding the effect of currency swings and resolution of tax disputes in 2023, up from previous estimates of "mid single-digit" percentage growth. Shares were up 2.4% in morning trading, after earlier rising as much as 4% to a one-year high. First-half adjusted operating profit gained 4% to 11.3 billion Swiss francs ($12.8 billion), the family-controlled drugmaker said on Thursday, beating analysts' consensus estimate of 10.5 billion, based on LSEG data. Read more from Reuters 👇🏼

3

With only weeks to go until LogiPharma Connect 2024, we’re gearing up for an extraordinary gathering of pharma industry leaders at the Fairmont Le Montreux Palace in Montreux, Switzerland. One of the key themes we will be exploring this year is Re-Establishing Foundations for SC Digital Transformation. For life sciences supply chains to stay competitive, resilient, and prepared for future demands, a shift in mindset and organisational culture is essential. Success in this area goes beyond technology alone; it’s about building a workforce that embraces change, supports innovation, and strengthens the foundation for digital advancement across supply chains. Our agenda will feature several deep-dive sessions to explore these challenges and opportunities. The Keynote Panel & Collaborative Discussion will address the culture and mindset shifts essential for SC 4.0, offering practical strategies and proven “hacks” for change management. Leaders will also share insights on what’s truly working—and what isn’t—in building digital resilience. We’ll also host a Fireside Chat on Intelligent Orchestration, focusing on how organisations can link end-to-end supply chain networks to optimise visibility and collaboration across stakeholders. We’ll explore best practices for integrating AI and real-time data to drive revenue and resilience across the supply chain. Join us at LogiPharma Connect to reshape the future of pharma supply chains. The countdown is on! Click here to view our full agenda: https://lnkd.in/ezBvrxEK #LogiPharma4Connect #SupplyChain #DigitalTransformation #PharmaLeadership #LifeSciences

34